L.‐O. Farnebo

1.3k total citations
10 papers, 432 citations indexed

About

L.‐O. Farnebo is a scholar working on Surgery, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, L.‐O. Farnebo has authored 10 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in L.‐O. Farnebo's work include Receptor Mechanisms and Signaling (2 papers), Thyroid and Parathyroid Surgery (2 papers) and Parathyroid Disorders and Treatments (2 papers). L.‐O. Farnebo is often cited by papers focused on Receptor Mechanisms and Signaling (2 papers), Thyroid and Parathyroid Surgery (2 papers) and Parathyroid Disorders and Treatments (2 papers). L.‐O. Farnebo collaborates with scholars based in Sweden and Denmark. L.‐O. Farnebo's co-authors include Bertil Hamberger, Martin Bäckdahl, Magnus Kjellman, Gert Auer, Olli Kallioniemi, Ritva Karhu, Chatarina Larsson, Anders Höög, G. Jönsson and Peter Lidbrink and has published in prestigious journals such as Journal of Neurochemistry, The Journal of Urology and British Journal of Pharmacology.

In The Last Decade

L.‐O. Farnebo

10 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.‐O. Farnebo Sweden 9 184 155 130 99 66 10 432
Juan A. Barbosa United States 10 313 1.7× 143 0.9× 71 0.5× 25 0.3× 156 2.4× 12 546
Laura L. Souza Brazil 8 137 0.7× 109 0.7× 39 0.3× 16 0.2× 69 1.0× 10 450
Teresa Procopio Italy 11 179 1.0× 93 0.6× 72 0.6× 34 0.3× 186 2.8× 13 532
P. R. Urquilla United States 10 243 1.3× 97 0.6× 25 0.2× 13 0.1× 45 0.7× 21 476
Nobutaka Ohkubo Japan 11 275 1.5× 94 0.6× 43 0.3× 48 0.5× 26 0.4× 18 510
Yoshio Asano Japan 10 221 1.2× 57 0.4× 28 0.2× 25 0.3× 22 0.3× 19 459
Nicolas Pelisch Japan 14 129 0.7× 60 0.4× 40 0.3× 25 0.3× 91 1.4× 18 477
A Terashi Japan 9 103 0.6× 94 0.6× 51 0.4× 19 0.2× 10 0.2× 39 432
Eishi Hara Japan 10 362 2.0× 123 0.8× 28 0.2× 27 0.3× 32 0.5× 13 482
Sun‐Zhong Mao China 12 134 0.7× 63 0.4× 104 0.8× 70 0.7× 19 0.3× 27 425

Countries citing papers authored by L.‐O. Farnebo

Since Specialization
Citations

This map shows the geographic impact of L.‐O. Farnebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.‐O. Farnebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.‐O. Farnebo more than expected).

Fields of papers citing papers by L.‐O. Farnebo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.‐O. Farnebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.‐O. Farnebo. The network helps show where L.‐O. Farnebo may publish in the future.

Co-authorship network of co-authors of L.‐O. Farnebo

This figure shows the co-authorship network connecting the top 25 collaborators of L.‐O. Farnebo. A scholar is included among the top collaborators of L.‐O. Farnebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.‐O. Farnebo. L.‐O. Farnebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kjellman, Petra, Jan Zedenius, G. E. F. Lundell, et al.. (2006). Predictors of outcome in patients with papillary thyroid carcinoma. European Journal of Surgical Oncology. 32(3). 345–352. 19 indexed citations
2.
Farnebo, L.‐O.. (2004). Primary Hyperparathyroidism. Update on Pathophysiology, Clinical Presentation and Surgical Treatment. Scandinavian Journal of Surgery. 93(4). 282–287. 2 indexed citations
3.
Kjellman, Magnus, Olli Kallioniemi, Ritva Karhu, et al.. (1996). Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.. PubMed. 56(18). 4219–23. 150 indexed citations
4.
Hamberger, Bertil, et al.. (1984). Primary Hyperparathyroidism. Changing Trends Over Fifty Years. The Journal of Urology. 132(1). 201–201. 16 indexed citations
5.
Andersson, Peter, L.‐O. Farnebo, Bertil B. Fredholm, et al.. (1982). Metabolic and hormonal adjustments during hemorrhage in cats after interference with the sympatho‐adrenal system. Acta Physiologica Scandinavica. 114(1). 111–119. 13 indexed citations
6.
Angerås, Ulf, L.‐O. Farnebo, H. Graffner, et al.. (1982). Effects of Food on Plasma Catecholamine and Gastrin Levels in Patients with Duodenal Ulcer and Normal Volunteers. Digestion. 25(3). 205–210. 10 indexed citations
7.
Farnebo, L.‐O., H. Hällman, Bertil Hamberger, & G. Jönsson. (1979). Catecholamines and hemorrhagic shock in awake and anesthetized rats.. PubMed. 6(2). 109–18. 25 indexed citations
8.
Lidbrink, Peter & L.‐O. Farnebo. (1973). Uptake and release of noradrenaline in rat cerebral cortex in vitro: No effect of benzodiazepines and barbiturates. Neuropharmacology. 12(11). 1087–1095. 22 indexed citations
9.
Farnebo, L.‐O. & Bertil Hamberger. (1971). Drug‐induced changes in the release of [3H]‐noradrenaline from field stimulated rat iris. British Journal of Pharmacology. 43(1). 97–106. 158 indexed citations
10.
Farnebo, L.‐O., Bertil Hamberger, & G. Jönsson. (1971). RELEASE OF [3H]NORADRENALINE AND [3H]DOPAMINE FROM FIELD STIMULATED CEREBRAL CORTEX SLICES EFFECT OF TYROSINE HYDROXYLASE AND DOPAMINE‐β‐HYDROXYLASE INHIBITION.1. Journal of Neurochemistry. 18(12). 2491–2500. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026